原发性肝癌切除术后门静脉血流障碍的处理进展

Research advances in portal vein blood disorder after liver resection for hepatocellular carcinoma

门静脉血流障碍是原发性肝癌切除术后的一种少见的并发症,且临床表现不明显,病死率高,相关研究报道较少,仍未能引起临床医师足够重视。至今,对于原发性肝癌术后门静脉血流障碍的诊治尚未达成共识。近年来,随着临床诊疗技术的提高和对该并发症认识的深入,其对原发性肝癌切除术的患者治疗越来越受到肝胆外科医生的关注。该文针对原发性肝癌切除术后门静脉血流障碍的流行病学、病因及发生机制、临床表现、相关诊疗及预防作一综述。

Portal vein blood disorder is a rare complication after liver resection for hepatocellular carcinoma,with not obvious clinical manifestations,high mortality and less relevant research information,which failed to arouse the attention of clinicians. Nowadays,there is no consensus on the diagnosis and treatment of postoperative portal vein blood disorder in primary hepatocellular carcinoma. In recent years,with the improvement of the clinical diagnosis and treatment technology and understanding the complications deeply,the influence of portal vein blood disorder in patients with primary hepatocellular carcinoma resection has been taken seriously by hepatobiliary sur-geon. This article reviews the epidemiology,etiology and mechanism,clinical presentation,prevention,diagnosis and treatment of portal vein blood flow obstruction after primary hepatectomy.